首页 正文

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent

{{output}}
The development of an effective prophylactic hepatitis C virus (HCV) vaccine is a priority to achieve global elimination of the virus. Accurate assessment of the neutralizing breadth of antibodies induced by vaccines and a clear understanding of the antigenic ... ...